Company Encyclopedia
View More
name
iShares MSCI USA Min Vol Factor ETF
USMV.US
News
View More

Is Cencora (COR) Quietly Rewriting Its Moat With an Aggressive Bet on Cryogenic Logistics?

Cencora is expanding its logistics capabilities with investments in cold chain and cryogenic storage, including new facilities in Texas and Italy, and acquiring NextPharma Logistics. This expansion aims to enhance its role in complex therapies logistics, potentially improving earnings quality. However, it also raises concerns about margin pressure and balance sheet impact. Cencora projects $385.4 billion revenue and $3.3 billion earnings by 2028, with a fair value estimate of $384.79 per share, indicating a 14% upside. Investors are advised to consider the risks and rewards of these strategic moves.

Simplywall·
US
COR
+0.69%
Simplywall·
US
COR
+0.69%

Chubb EVP Makes a Multi-Million Dollar Stock Sale!

Chubb's EVP Juan Luis Ortega sold 4,357 shares worth $1,285,489. Morgan Stanley and UBS raised Chubb's price target, citing positive market sentiment and insurance sector updates. Chubb faces leadership changes with Vice Chairman John Lupica's retirement. Spark rates CB as Outperform, noting strong financial performance but cautioning on overbought signals. Chubb's YTD price performance is 7.86%, with a market cap of $115.9B.

Tip Ranks·
US
MS
+0.67%
US
CB
-0.14%
Tip Ranks·
US
MS
+0.67%
US
CB
-0.14%

Leon Stok of IBM Elected Chair of Silicon Integration Initiative Board

Dr. Leon Stok, VP of Electronic Design Automation at IBM, has been elected Chair of the Silicon Integration Initiative (Si2) Board for the 2025–2026 term. Dr. Stok, a recognized leader in EDA, has been on the Si2 Board since 2007 and has held various leadership roles. Si2 is a global organization with 70 corporate members focused on semiconductor design standards and solutions.

fidelity·
US
IBM
+1.77%
US
SOXL
-3.05%
fidelity·
US
IBM
+1.77%
US
SOXL
-3.05%

International Business Machines (NYSE:IBM) Shares Up 1.7% - Here's Why

IBM's stock rose 1.7% to $307.82, with a trading volume decline of 40%. Analysts have mixed ratings: Wall Street Zen upgraded to 'buy', Morgan Stanley set 'equal weight', and Stifel Nicolaus reduced price objective to $295. IBM reported Q3 EPS of $2.65, beating estimates, with revenue up 9.1% year-over-year. The company announced a quarterly dividend of $1.68 per share, with a yield of 2.2%. Hedge funds own 58.96% of IBM's stock.

Market Beat·
US
IBM
+1.77%
Market Beat·
US
IBM
+1.77%

Health Care Down Sharply on Rotation to Rate-Sensitive Sectors -- Health Care Roundup

Health-care stocks fell sharply as traders shifted to rate-sensitive sectors. Halozyme secured a preliminary injunction against Merck & Co. in a patent dispute over Keytruda in Germany. The Trump administration's biomedical innovation goals face challenges within the FDA, amid infighting and staff turnover influenced by Robert F. Kennedy Jr.'s policy changes.

marketscreener·
US
MRK
-1.35%
US
HALO
-2.64%
marketscreener·
US
MRK
-1.35%
US
HALO
-2.64%
Posts
View More
© 2025 Longbridge｜Disclaimer